1 August 2023 – Minneapolis, MN United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX: IMR), the global leader in real-time iCMR cardiac ablation products, is pleased to announce it has received approval from the Medical Ethics Review Committee, Leiden The Hague Delft (METC LDD) to begin the VISABL-VT trial at Haga Hospital in The Hague, Netherlands. The … Read More

31 July 2023 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in real-time iCMR cardiac ablation products, is pleased to announce it has entered into a Distribution Agreement with Al Faisaliah Medical Systems (FMS) Subsidiary of Tibbiyah Holding Company, a prominent distributor in the Kingdom of Saudi Arabia (KSA). Under the terms … Read More

Minneapolis MN (July 11 2023) – Imricor Medical Systems, Inc. (ASX:IMR) Imricor, the global leader in real-time interventional cardiac magnetic resonance (iCMR) ablation products, is pleased announce it has entered into a non-exclusive software distribution agreement with ADAS 3D Medical S.L. (ADAS 3D Medical) a leading developer of imaging solutions for the electrophysiology (EP) market.

April 11 – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR), the global leader in real-time iCMR cardiac ablation products, is pleased to announce that the University Hospital Lausanne (CHUV) in Lausanne, Switzerland has submitted a purchase order to Imricor for the capital equipment required to fit out the CHUV’s new iCMR lab, scheduled to open this July.

Minneapolis MN (January 25, 2023) – Imricor Medical Systems, Inc. (ASX:IMR) Imricor, the global leader in real-time interventional cardiac magnetic resonance (iCMR) ablation products, is pleased to announce that it has entered into a Memorandum of Understanding (MOU) with GE HealthCare.

At the Helios Klinikum Berlin-Buch, catheter ablation was performed using a cardiac MRI. For the first time, a team of cardiologists has paired the standard procedure of catheter ablation with a cardiac MRI. In the future, this new method promises to improve the treatment of complex cardiac arrhythmias through real-time imaging and more precise treatment of heart tissue. The head of the Heart Rhythm Center Berlin/Brandenburg at the Helios Klinikum Berlin-Buch Dr. med. Michael Wiedemann explains the innovative process in an interview. 

22 September 2022 – Minneapolis, MN United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR), the global leader in real-time iCMR cardiac ablation products, is pleased to announce that the Company has submitted for approval to commence a real-time iCMR-guided ventricular tachycardia (VT) ablation clinical trial.

11 August 2022 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in realtime interventional cardiac magnetic resonance (iCMR) cardiac ablation products, is pleased to announce it has entered into two new agreements with Siemens Healthineers that together provide Imricor the ability to deploy the Company’s new 3D mapping system on the Siemens Healthineers Magnetic Resonance Imaging (MRI) platform.

31 March 2022 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in Realtime iCMR cardiac ablation products, is pleased to announce it has entered into a Development Agreement with Mammendorfer Institut für Physik und Medizin GmbH (MIPM), a leading developer and manufacturer of MRI-compatible medical devices, including an MRI-compatible external cardioverter defibrillator. MIPM … Read More

11 February 2022 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in realtime iCMR cardiac ablation products, today announced the scheduled retirement of its Chief Financial Officer, Ms Lori Milbrandt, and the appointment of Mr Jonathon Gut as the incoming Chief Financial Officer.